PDCD1 and clear cell renal carcinoma: For instance, in metastatic clear cell renal cell carcinoma, higher levels of PD-1+ intratumoural Tregs were associated with a lack of benefit from anti-PD-1 therapy, suggesting that these cells contribute to an immunosuppressive TME that resists PD-1 inhibition [192].